RE: Why not US2 Apr 2020 11:25
The world of large pharmas are a fickle bunch.
Seems the US are trying to make things work.. closed within their boarders. They tried to buy a german company who were working on a vaccine the other week to keep it all to themselves.
The remap cap study is international... far more open to the world.
This is a great opportunity for paitents and faron
From the RNS Which was repeated on the interview:
"As this trial also has a hydrocortisone arm, it will provide a direct efficacy comparison between IFN beta-1a and hydrocortisone, and will provide further prospective data on the concomitant use of these treatments, following previous observations that the use of overlapping corticosteroids are likely to have a deleterious effect on IFN beta-1a"